Broker Forecast - JP Morgan Cazenove issues a broker note on GlaxoSmithKline PLC

Writer,

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

JP Morgan Cazenove today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1750p (from 1900p).

Broker Forecasts data provided by www.sharesmagazine.co.uk